Laboratory device for the further development of the CTR test is financed by the Rudolf Bartling Foundation
As a non-profit organization, TherapySelect non-profit has submitted an application to the Rudolf Bartling Foundation to finance a laboratory device.
We are pleased that the application was approved and that we received a commitment this month (December 2023). The device will be delivered by Promega in January 2024 and will provide us with important services in the further development of the CTR test.
We would like to take this opportunity to thank the foundation for classifying us as eligible for funding this year in its efforts to support research institutions.